EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Matrix metalloproteinases in intestinal fibrosis

Carin Biel iD, Klaas Nico Faber, Ruud A Bank, Peter Olinga iD

Journal of Crohn's and Colitis · 01.03.2024 · 18 (3) · 462-478

DOI: 10.1093/ecco-jcc/jjad178 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Crohn's and Colitis, online erschienen am 25.10.2023. Verfasst von Carin Biel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, the Netherlands. Hauptthemen laut MEDLINE: Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal fibrosis is a common complication in patients with inflammatory bowel disease [IBD], in particular Crohn’s disease [CD]. Unfortunately, at present intestinal fibrosis is not yet preventable, and cannot be treated by interventions other than surgical removal. Intestinal fibrosis is characterized by excessive accumulation of extracellular matrix [ECM], which is caused by activated fibroblasts and smooth muscle cells. Accumulation of ECM results from an imbalanced production and degradation of ECM. ECM degradation is mainly performed by matrix metalloproteinases [MMPs], enzymes that are counteracted by tissue inhibitors of MMPs [TIMPs]. In IBD patients, MMP activity [together with other protease activities] is increased. At the same time, CD patients have a generally lower MMP activity compared to ulcerative colitis patients, who usually do not develop intestinal strictures or fibrosis. The exact regulation and role[s] of these MMPs in fibrosis are far from understood. Here, we review the current literature about ECM remodelling by MMPs in intestinal fibrosis and their potential role as biomarkers for disease progression or druggable targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseInflammatory Bowel DiseasesHumansIntestinesFibrosisMatrix Metalloproteinases

Substanzen

Matrix Metalloproteinases

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, the Netherlands.
  • Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

ORCID-Profile: Carin Biel, Peter Olinga

Zitieren

APA

Biel, C., Faber, K. N., Bank, R. A., & Olinga, P. (2024). Matrix metalloproteinases in intestinal fibrosis. Journal of Crohn's and Colitis, 18(3), 462-478. https://doi.org/10.1093/ecco-jcc/jjad178

Vancouver

Biel C, Faber KN, Bank RA, Olinga P. Matrix metalloproteinases in intestinal fibrosis. Journal of Crohn's and Colitis. 2024;18(3):462-478. doi:10.1093/ecco-jcc/jjad178

BibTeX
@article{Biel2024,
  author = {Biel, Carin and Faber, Klaas Nico and Bank, Ruud A and Olinga, Peter},
  title = {Matrix metalloproteinases in intestinal fibrosis},
  journal = {Journal of Crohn's and Colitis},
  year = {2024},
  volume = {18},
  number = {3},
  pages = {462--478},
  doi = {10.1093/ecco-jcc/jjad178}
}
Kostenlos starten →